12-55452303-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_054105.2(OR6C2):c.90T>A(p.Phe30Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_054105.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR6C2 | NM_054105.2 | c.90T>A | p.Phe30Leu | missense_variant | 2/2 | ENST00000641202.1 | |
LOC124902940 | XR_007063324.1 | n.88+183A>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR6C2 | ENST00000641202.1 | c.90T>A | p.Phe30Leu | missense_variant | 2/2 | NM_054105.2 | P1 | ||
ENST00000556750.5 | n.179-17172A>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250834Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135566
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461254Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726892
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2022 | The c.90T>A (p.F30L) alteration is located in exon 1 (coding exon 1) of the OR6C2 gene. This alteration results from a T to A substitution at nucleotide position 90, causing the phenylalanine (F) at amino acid position 30 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at